3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
522
Leukemia, Myeloid, Acute
498
Neoplasms
380
Carcinoma, Non-Small-Cell Lung
379
Pancreatic Neoplasms
328
Precursor Cell Lymphoblastic Leukemia-Lymphoma
318
Multiple Myeloma
311
Glioblastoma
311
Melanoma
309
Prostatic Neoplasms
293
Leukemia
288
Neoplasm Metastasis
284
Brain Neoplasms
275
Lymphoma
271
Lung Neoplasms
269
Recurrence
266
Ovarian Neoplasms
247
Colorectal Neoplasms
246
Lymphoma, Non-Hodgkin
241
Leukemia, Lymphocytic, Chronic, B-Cell
231
Myelodysplastic Syndromes
208
Glioma
208
Lymphoma, Large B-Cell, Diffuse
186
Carcinoma, Hepatocellular
173
Lymphoma, Follicular
167
Head and Neck Neoplasms
161
Hodgkin Disease
160
Lymphoma, Mantle-Cell
155
Burkitt Lymphoma
154
Sarcoma
150
Interventions
Vinorelbine
1
Interferon alpha-2
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
OTHER
×
Advanced Neoplasm
×
Clear all
NCT00908869
2012-01-30
METRO1
Institut Paoli-Calmettes
Phase 1
Completed
30 enrolled